3rd Annual Neuroscience R&D Technologies Conference is organized by MarketsandMarkets(MnM) Research Private Ltd and would be held during Sep 28 - 29, 2017 at Radisson Blu Edwardian Heathrow Hotel, London, England, United Kingdom.
The conference aims to focus on sharing the current market trends, technological advancements and future challenges in the pre-clinical neuroscience research where the leading experts from the pharma industry and research institutes will discuss the latest technologies in Neuroscience R&D by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
Key Highlights :
• Drug target validation technologies in CNS drug discovery
• Translational Imaging technologies-EEG, EMG, FMRI for assessment of CNS function
• Optogenetic tools used in brain mapping
• Novel neuroprostheses and neuromodulation for treating CNS disorders
• Translational animal models for CNS disorders
• Neuroinformatics and Computational Neuroscience
Who Should Attend?
From Pharmaceutical, Academics and Research Institutes
Chief Scientific Officer/Directors/Heads/VP/Managers/Senior Scientists/ Principal/ Scientist/ Neuroscientists/ Project Leaders/ Professors/Research Fellows in:
• Neuroscience/CNS drug discovery
• Translational Neuroscience
• Pre-clinical research
• Computational Neuroscience/Neuroinformatics
• Neurotechnology
• Neuroimaging/Translational Imaging
• Neurodegenerative diseases
• Neuroengineering
• Neuropharmacology/Neurobiology
• Neuromorphic engineers
Why Attend?
• First ever conference on application of technology in developing neurological treatments
• Meet global heads of neuroscience from the industry and Academics
• 100+ neuroscience professionals attending
• Access to online presentations on-demand post-summit
• Case studies presented from leading technology collaborations
• Interactive panel and breakout sessions
Additional details will be posted as soon as they are available.